CELLECTA, INC.

CELLECTA, INC. specializes in advanced biotechnology research and development, with a focus on precision molecular tools and laboratory validation services. The company delivers cutting-edge R&D solutions in non-nanobiotechnology domains, including gene editing, functional genomics, and target validation platforms, supporting both defense and public health initiatives. Their technical expertise encompasses high-throughput screening, nucleic acid library design, and analytical validation protocols aligned with GLP and GMP standards. A key differentiator is their ability to bridge early-stage biological discovery with scalable laboratory testing frameworks, ensuring reproducible outcomes for complex therapeutic and diagnostic applications. The contractor has demonstrated direct engagement with the Department of Health and Human Services and the Department of Defense, providing specialized testing services and biotechnology R&D support. For HHS, this includes laboratory validation and analytical service delivery, while for DoD, the work centers on applied biotechnological research aimed at defense-relevant health threats. These relationships suggest a pattern of mission-driven collaboration, where CELLECTA serves as a technical partner in developing novel biological solutions under stringent regulatory and operational constraints. The primary NAICS codes reflect a focused industry positioning in biotechnology R&D and laboratory testing services. In practice, this means CELLECTA operates at the intersection of molecular biology and regulated testing, serving sectors requiring high-fidelity data generation and compliance with federal biosafety and quality standards. Their vertical specialization lies in translational biotechnology, supporting the development of next-generation therapeutics and diagnostics through rigorous experimental design and analytical rigor. As a small business structured as a 2L entity based in Mountain View, California, CELLECTA operates with agility in the federal biotech marketplace. While no government certifications are currently listed, its geographic location places it within a major innovation corridor, facilitating access to academic, biotech, and defense research ecosystems. The company’s market positioning is that of a nimble, technically specialized provider of mission-critical biotechnology services to federal agencies.